Asymmetrex President and CEO James L. Sherley, M.D., Ph.D. recently contributed a chapter to a new book on Stem Cell Veterinary Science that highlights the advantages of stem cell-specific dosing for improving the effectiveness of new stem cell treatment approaches. Dr. Sherley caught up with Tech Company News to speak about this chapter and how stem cell-specific dosing in veterinary medicine promotes improved stem cell treatments.
“The chapter that I co-authored in the new volume, Stem Cells in Veterinary Science, is the latest example of how Asymmetrex is working to better inform the stem cell medicine veterinarian community towards adoption of KSC counting into their medical practice. Knowing the dosage of the stem cells they use to treat pets, sports animals, and farm animals will improve the effectiveness of their clinical research and current treatments. Their achievement of benefits for animals should motivate stem cell physicians to do the same.”